InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,168.40
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.88
(
0.48%
)
Bitcoin
60,658.50
(
-0.25%
)
Post# of 252390
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: pcrutch post# 119264

Tuesday, 05/03/2011 10:22:02 AM

Tuesday, May 03, 2011 10:22:02 AM

Post# of 252390
Thanks. There's actually 2 more ARIA abstracts:

Abstract #5013
Phase II study of oral ridaforolimus in patients with metastatic and/or locally advanced recurrent endometrial cancer: NCIC CTG IND 192.
Helen Mackay, MD
Poster: 2

Abstract #10080
Effect of the combination of mTOR inhibitor ridaforolimus and HDAC inhibitor vorinostat on in vitro synergism in synovial sarcoma, osteosarcoma, and a range of other tumor subtypes.
Sherif S. Morgan, PhD
Poster: 49G
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up